Clinical outcomes of intravenous immunoglobulin therapy in COVID-19 related acute respiratory distress syndrome: a retrospective cohort study

Clinical outcomes of intravenous immunoglobulin therapy in COVID-19 related acute respiratory distress syndrome: a retrospective cohort study

Abstract Background Intravenous immunoglobulin (IVIG) has been used as an immunomodulatory therapy to counteract severe systemic inflammation in coronavirus disease 2019 (COVID-19). But its use in COVID-19 related acute respiratory distress syndrome (ARDS) is not well established. Methods We conduct...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Husain S. Ali, Moustafa S. Elshafei, Mohamed O. Saad, Hassan A. Mitwally, Mohammad Al Wraidat, Asra Aroos, Nissar Shaikh, Dore C. Ananthegowda, Mohamed A. Abdelaty, Saibu George, Abdulqadir J. Nashwan, Ahmed S. Mohamed, Mohamad Y. Khatib
Formato: article
Lenguaje:EN
Publicado: BMC 2021
Materias:
Acute respiratory distress syndrome
COVID-19
ICU mortality
Intravenous immunoglobulin
Mechanical ventilation
Diseases of the respiratory system
RC705-779
Acceso en línea:https://doaj.org/article/386dc40f31d34a41ab3d998b93a9a9e6
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/386dc40f31d34a41ab3d998b93a9a9e6

Ejemplares similares